Suppr超能文献

一种新型血管生成因子富含亮氨酸的α2-糖蛋白(LRG1)水平升高与2型糖尿病患者的动脉僵硬度、内皮功能障碍和外周动脉疾病相关。

Elevation of a novel angiogenic factor, leucine-rich-α2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes.

作者信息

Pek Sharon L T, Tavintharan S, Wang Xiaomeng, Lim Su Chi, Woon Kaing, Yeoh Lee Ying, Ng Xiaowei, Liu Jianjun, Sum Chee Fang

机构信息

Clinical Research Unit (S.L.T.P., S.T., S.C.L., K.W., X.N., J.L.), Diabetes Centre (S.T., S.C.L., C.F.S.), and Division of Endocrinology (S.T., S.C.L., C.F.S.), Khoo Teck Puat Hospital, Singapore 768828; Metabolic Disease Research Programme (X.W.), Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 639798; Division of Nephrology (L.Y.Y.), Department of Medicine, Khoo Teck Puat Hospital, Singapore 768828; Institute of Molecular and Cell Biology (X.W.), A*STAR, Singapore 138673; and Institute of Ophthalmology (X.W.), University College London, London EC1V 9EL, United Kingdom.

出版信息

J Clin Endocrinol Metab. 2015 Apr;100(4):1586-93. doi: 10.1210/jc.2014-3855. Epub 2015 Jan 30.

Abstract

CONTEXT

Increased arterial stiffness and endothelial dysfunction are associated with peripheral arterial disease (PAD). Leucine-rich-α2-glycoprotein (LRG1) is a proangiogenic factor involved in regulation of the TGFβ signaling pathway.

OBJECTIVE

This study in patients with type 2 diabetes mellitus explored the associations of plasma LRG1 with arterial stiffness, endothelial function, and PAD.

DESIGN

Based on the ankle brachial index (ABI), patients were classified as having PAD (ABI ≤ 0.9) or as being borderline abnormal (ABI, 0.91-0.99) or normal (ABI, 1.00-1.40). LRG1 was measured by immunoassay; arterial stiffness, by carotid-femoral pulse-wave velocity and augmentation index; and endothelial function, by laser Doppler flowmetry.

RESULTS

A total of 2058 patients with type 2 diabetes mellitus were recruited. Mean age (1 SD) was 57.4 (0.2) years. Patients with PAD (n = 258) had significantly higher LRG1 compared to patients with borderline ABI and patients without PAD (19.00 [13.50] vs 17.35 [13.30] and 15.28 [10.40] μg/mL, respectively; P < .0001). Multiple regression analysis revealed that female gender (P < .0001), non-Chinese ethnicity (P < .0001), higher waist circumference (P = .017), lower estimated glomerular filtration rate (P < .0001), higher urine albumin-creatinine ratio (P = .009), lower ABI (P < .0001), higher pulse wave velocity (P = .040), and poorer endothelium-dependent vasodilation (P = .007) were independent significant predictors of higher plasma LRG1 levels. A generalized linear model showed that a 1-SD increase in log LRG1 was associated with an odds ratio of 4.072 (95% confidence interval, 1.889-8.777; P < .0001) for prevalence of PAD, after adjustment for traditional risk factors.

CONCLUSIONS

Higher LRG1 is a significant predictor for arterial stiffness, endothelial function, and PAD. The pathobiological basis and the temporal relationships of these associations need to be explored by further mechanistic and prospective studies to understand the clinical significance of these findings.

摘要

背景

动脉僵硬度增加和内皮功能障碍与外周动脉疾病(PAD)相关。富含亮氨酸的α2-糖蛋白(LRG1)是一种参与转化生长因子β信号通路调节的促血管生成因子。

目的

本研究在2型糖尿病患者中探讨血浆LRG1与动脉僵硬度、内皮功能和PAD之间的关联。

设计

根据踝臂指数(ABI),将患者分为患有PAD(ABI≤0.9)、临界异常(ABI,0.91 - 0.99)或正常(ABI,1.00 - 1.40)。通过免疫测定法测量LRG1;通过颈股脉搏波速度和增强指数测量动脉僵硬度;通过激光多普勒血流仪测量内皮功能。

结果

共招募了2058例2型糖尿病患者。平均年龄(1个标准差)为57.4(0.2)岁。与临界ABI患者和无PAD患者相比,PAD患者(n = 258)的LRG1显著更高(分别为19.00 [13.50] vs 17.35 [13.30]和15.28 [10.40] μg/mL;P <.0001)。多元回归分析显示,女性(P <.0001)、非华裔(P <.0001)、较高的腰围(P =.017)、较低的估计肾小球滤过率(P <.0001)、较高的尿白蛋白肌酐比值(P =.009)、较低的ABI(P <.0001)、较高的脉搏波速度(P =.040)和较差的内皮依赖性血管舒张(P =.007)是血浆LRG1水平升高的独立显著预测因素。广义线性模型显示,在调整传统危险因素后,log LRG1每增加1个标准差与PAD患病率的比值比为4.072(95%置信区间,1.889 - 8.777;P <.0001)相关。

结论

较高的LRG1是动脉僵硬度、内皮功能和PAD的重要预测指标。这些关联的病理生物学基础和时间关系需要通过进一步的机制研究和前瞻性研究来探索,以了解这些发现的临床意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验